MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 113 filers reported holding MERSANA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,002,865 | -61.4% | 8,663,673 | 0.0% | 1.23% | -58.1% |
| Q2 2023 | $28,503,484 | +79948.0% | 8,663,673 | 0.0% | 2.94% | -34.0% |
| Q1 2023 | $35,608 | -29.9% | 8,663,673 | 0.0% | 4.45% | -21.6% |
| Q4 2022 | $50,769 | -99.9% | 8,663,673 | 0.0% | 5.67% | -18.9% |
| Q3 2022 | $58,566,000 | +46.3% | 8,663,673 | 0.0% | 6.99% | +48.9% |
| Q2 2022 | $40,026,000 | +53.8% | 8,663,673 | +32.8% | 4.69% | +85.8% |
| Q1 2022 | $26,023,000 | -22.3% | 6,522,030 | +21.1% | 2.53% | -4.9% |
| Q4 2021 | $33,499,000 | -3.9% | 5,385,667 | +45.7% | 2.66% | +22.9% |
| Q3 2021 | $34,850,000 | -30.6% | 3,695,667 | 0.0% | 2.16% | -34.2% |
| Q2 2021 | $50,187,000 | -16.1% | 3,695,667 | 0.0% | 3.29% | -2.9% |
| Q1 2021 | $59,796,000 | -34.8% | 3,695,667 | +7.3% | 3.39% | -41.2% |
| Q4 2020 | $91,689,000 | +42.9% | 3,445,667 | 0.0% | 5.76% | -3.7% |
| Q3 2020 | $64,158,000 | -20.4% | 3,445,667 | 0.0% | 5.98% | -29.2% |
| Q2 2020 | $80,629,000 | – | 3,445,667 | – | 8.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $4,564,000 | 3.47% |
| NEA Management Company, LLC | 11,963,649 | $68,552,000 | 3.24% |
| Sarissa Capital Management LP | 3,750,000 | $21,487,000 | 1.78% |
| VHCP Management III, LLC | 1,561,389 | $8,947,000 | 1.78% |
| VHCP Management II, LLC | 922,514 | $5,286,000 | 1.39% |
| Ghost Tree Capital, LLC | 800,000 | $4,584,000 | 0.87% |
| BVF INC/IL | 1,180,553 | $6,765,000 | 0.51% |
| Sio Capital Management, LLC | 166,250 | $953,000 | 0.23% |
| Rock Springs Capital Management LP | 1,233,000 | $7,065,000 | 0.22% |
| DAFNA Capital Management LLC | 108,463 | $621,000 | 0.21% |